Agile Therapeutics Announces Publication of Data on

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Agile Therapeutics Announces Publication of Data on Low-Dose Investigational Contraceptive Patch

PRINCETON, N.J., Dec. 1, 2014 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX ) today announced the publication of two manuscripts containing data from a Phase 3 clinical trial of Twirla ® (AG200-15), an investigational, once-weekly contraceptive patch.

Kaunitz A, Portman D, Westhoff C, Mishell D, Archer D, Foegh M. New Contraceptive Patch Wearability Assessed by Investigators and Participants in a Randomized, Phase 3 Study . Contraception 2014 DOI: http://dx.doi.org/10.1016/j.contraception.2014.11.013

Kaunitz A, Portman D, Westhoff C, Archer D, Mishell, D, Foegh M.  Self-Reported and Verified Compliance in a Phase 3 Clinical Trial of a Novel Low-Dose Contraceptive Patch and Pill . Contraception 2014 DOI: http://dx.doi.org/10.1016/j.contraception.2014.11.011

Agile recently initiated an additional Phase 3 trial with Twirla, the SECURE study, which will provide further data on the safety, tolerability, and effectiveness of this low-dose contraceptive patch.

About Agile

Agile Therapeutics is a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products. Our product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. Our lead product candidate, Twirla ® , (ethinyl estradiol and levonorgestrel transdermal system), also known as AG200-15, is a once-weekly prescription contraceptive patch currently in Phase 3 clinical development. Twirla is based on our proprietary transdermal patch technology, called Skinfusion ® , which is designed to provide advantages over currently available patches and is intended to optimize patch adherence and patient acceptability. For more information, please visit the company website at www. agiletherapeutics.com.

Forward Looking Statement

Certain information contained in this press release includes "forward-looking statements" related to the Company's clinical trials. We may, in some cases use terms such as "predicts," "believes," "potential," "continue," "anticipates", "estimates," "expects," "plans," "intends," "may," "could," 'might," "will," "should" or other words that convey uncertainty of the future events or outcomes to identify these forward-looking statements. Our forward-looking statements are based on current expectations that involve risks, potential changes in circumstances, assumptions and uncertainties. Any or all of the forward-looking statements may turn out to be wrong, or be affected by inaccurate assumptions we might make or by known or unknown risks and uncertainties. For example, our statements regarding our statements about the timing and conduct of our clinical trial could be affected by the potential that we experience difficulty in identifying and initiating sites and enrolling subjects, we identify serious side effects or other safety issues, we do not have clinical supply of our product candidate that is adequate in amount and quality and supplied in a timely fashion, and the inherent risks of clinical development. For all these reasons, actual results and developments could be materially different from those expressed in or implied by our forward-looking statements. All forward looking statements are subject to risks detailed in our filings with the U.S. Securities and Exchange Commission, including the Company's Registration Statement on Form S-1, and the prospectus filed in connection therewith and our Reports on Form 10-Q.  You are cautioned not to place undue reliance on these forward-looking statements, which are made only as of the date of this press release. We undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

Mary Coleman 609-683-1880

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Katahdin's Portland Branch Bet Moves Downtown in 2027

Updated Category News Views 61

Exchange Street is getting a real-world vote of confidence, and that is more interesting than another app update ever will be. Katahdin Trust intends to open a full-service branch at 120 Exchange Street in downtown Portland, with renovations slated to begin early in 2027 and an opening expected later that year. For a Maine community bank with nearly $1.2 billion in...

Continue Reading
Washington-to-Asia Advisory Deal Targets Policy Risk

Updated Category News Views 10

Policy bottlenecks are becoming a cost center across Southeast Asia. That is the plain-English backdrop for the strategic partnership announced November 18, 2026, by Beacon Global Strategies and Vriens & Partners. Neither firm is selling a factory, a chip design, or a new energy project. They are selling something companies increasingly cannot afford to improvise: a...

Continue Reading
APEC's Shared-Prosperity Message Needs More Detail

Updated Category News Views 20

Geese make handsome symbols, but markets cannot underwrite a metaphor. The Nov. 18, 2026 report from Xinhua News Agency looks back to remarks Chinese President Xi Jinping made 12 years ago, when he used swan geese to urge APEC economies toward greater cooperation and a new collective flight. Its present-day message is plainly hopeful: the APEC family is moving across the...

Continue Reading
CVRx Lawsuit Deadline Follows a Brutal 59.76% Plunge

Updated Category News Views 24

A 59.76% one-day wipeout has a way of stripping the varnish off every upbeat corporate story. For CVRx investors, the hard fact is that the shares fell $3.55 to close at $2.39 on August 7, 2026, after the company disclosed a U.S. Department of Justice civil investigative demand in its August 6 Form 10-Q. That kind of disclosure does not merely dent confidence; it forces...

Continue Reading
Haemonetics Opens Europe for VASCADE MVP XL Device

Updated Category News Views 31

A larger collagen plug is hardly cocktail-party material, yet it can matter a great deal when it sits inside a procedure workflow hospitals are trying to speed up. Haemonetics has received CE Mark certification under the EU Medical Device Regulation for VASCADE MVP XL, its larger-bore venous vascular closure system, and first commercial European procedures were completed...

Continue Reading
Fapon’s Enzyme Push Meets Diagnostics Reality at AMP

Updated Category News Views 85

Enzymes rarely get applause at industry meetings, but they can quietly decide whether a diagnostic workflow behaves or becomes a lab headache. Fapon used its AMP 2026 appearance in Seattle to make that unglamorous case: better enzyme design may help assays move faster and keep working when samples get messy. The company wrapped up the November 10–14 meeting after...

Continue Reading
Photocure Opens a New Access Route for Hexvix Patients

Updated Category News Views 31

Forty-plus markets just moved from “not available” toward a workable route for individual bladder cancer patients, and that is the real substance of Photocure’s new arrangement with Clinigen. This is not a sweeping product launch, nor is it an approval announcement dressed up in confetti. It is a Named Patient Program, which matters because the regulatory plumbing...

Continue Reading
Kids First Data Sharing Raises Pediatric Research Bar

Updated Category News Views 68

Thirty-eight thousand children’s records are not a headline gimmick; they are a serious argument for treating research data as an asset that must keep working after the first study ends. The Gabriella Miller Kids First Data Resource Center’s ten-year review, published in the September 2026 issue of The American Journal of Human Genetics, makes that argument with...

Continue Reading
DEFSEC Tackles Nasdaq Bid Price Hurdle with Share Move

Updated Category News Views 68

Navigating Bid Price Deficiency Issues Well, it seems DEFSEC Technologies Inc. found themselves in a tricky spot last week. A nasty gram from Nasdaq’s Listing Qualifications Department pointing out that DEFSEC's shares had dipped below that $1.00 per share requirement for too long—a full 30 business days. Now, don't panic just yet. This isn't about the shares getting...

Continue Reading
WYBOT's New Robots Push Hands-Free Pool Care in Lyon

Updated Category News Views 0

A pool robot climbing out of the water to dock itself is the sort of demo that makes people stop mid-aisle at a trade show. WYBOT brought precisely that kind of attention-grabber to Piscine Global Lyon 2026, running November 17–20 at Eurexpo Lyon. The company is showing a broader lineup, but the M3 Pro is plainly the headline act: WYBOT calls it the world's first...

Continue Reading

Top 5 Most Recently Viewed Articles

Carrier Global Under Fire: An Investor's Investigation

Updated Category News Views 63

Sometimes the heat in the boardroom can match the heat of a summer's day. Enter Carrier Global Corporation (NYSE: CARR), where a group of folks who should've had their numbers kept tidy started playing with fire. Now there's an invite to a showdown from Schall, Brown & Schwartz LLP. They've thrown down the gauntlet to dig into whether Carrier’s statements could put them...

Continue Reading
Wise Group Faces Class Action Over Misleading Statements

Updated Category News Views 15

Wise Group plc: Legal Storm Brewing on the Horizon Looks like Wise Group's NASDAQ journey might be hitting some turbulence. Shareholders who picked up shares of the NASDAQ ticker WSE between May 11 and July 23, 2026, are getting a nudge to join a class action lawsuit that's gaining steam. Nothing sends a chill down a stockholder’s spine quite like the term "materially...

Continue Reading
FTI Consulting Enhances AI Capabilities with New Leadership

Updated Category News Views 151

FTI Consulting Announces New Senior Director for AI Innovation Global business advisory firm FTI Consulting, Inc. (NYSE: FCN), has recently appointed Brian Knudson as Senior Managing Director in the Data & Technology Transformation practice within the Corporate Finance & Restructuring segment. This strategic hire showcases FTI's commitment to enhancing its capabilities in...

Continue Reading
Viasat Launches Government Services via ViaSat-3 F1 Satellite

Updated Category News Views 156

Viasat Launches Government Services via ViaSat-3 F1 Satellite Viasat is now providing crucial satellite services to the U.S. Marine Corps using the ViaSat-3 network. This launch marks a significant stride towards enhancing connectivity for government operations. Connecting Military Operations The Marine Wing Communications Squadron 38 (MWCS-38) and the 3rd Marine Littoral...

Continue Reading
Automatic Trash Cans: A Game-Changer for Households

Updated Category News Views 87

Tired of Wrestling with Trash Cans? You'd think in this high-tech era, someone would've cracked the code on trash day drudgery. Well folks, the TRASH HAULER might just be the answer. Created by an inventive mind from Manhattan, Kansas, this gizmo is out to revolutionize the way we handle our garbage—by doing the heavy lifting for us on pickup day. The Idea Behind TRASH...

Continue Reading